6-69697573-A-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018368.4(LMBRD1):c.1407T>A(p.Asp469Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.39 in 1,596,448 control chromosomes in the GnomAD database, including 125,478 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_018368.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMBRD1 | NM_018368.4 | c.1407T>A | p.Asp469Glu | missense_variant | 14/16 | ENST00000649934.3 | NP_060838.3 | |
LMBRD1 | NM_001363722.2 | c.1188T>A | p.Asp396Glu | missense_variant | 14/16 | NP_001350651.1 | ||
LMBRD1 | NM_001367271.1 | c.1188T>A | p.Asp396Glu | missense_variant | 14/16 | NP_001354200.1 | ||
LMBRD1 | NM_001367272.1 | c.1188T>A | p.Asp396Glu | missense_variant | 14/16 | NP_001354201.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMBRD1 | ENST00000649934.3 | c.1407T>A | p.Asp469Glu | missense_variant | 14/16 | NM_018368.4 | ENSP00000497690.1 |
Frequencies
GnomAD3 genomes AF: 0.337 AC: 51203AN: 151820Hom.: 9683 Cov.: 32
GnomAD3 exomes AF: 0.394 AC: 98775AN: 250410Hom.: 20429 AF XY: 0.402 AC XY: 54481AN XY: 135426
GnomAD4 exome AF: 0.396 AC: 571560AN: 1444510Hom.: 115790 Cov.: 28 AF XY: 0.399 AC XY: 287062AN XY: 719688
GnomAD4 genome AF: 0.337 AC: 51225AN: 151938Hom.: 9688 Cov.: 32 AF XY: 0.337 AC XY: 25050AN XY: 74264
ClinVar
Submissions by phenotype
Methylmalonic aciduria and homocystinuria type cblF Benign:4
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 29, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at